China’s bio-technology company Yixi raised tens of millions of yuan in an angel round funding led by the co-funder of xinzitong.com Wang Xin. The investment will be used to conduct joint research with its hospital partners.
Established in 2019, Yixi develops alternative treatment solutions for diseases related to etheric organism, synthetic biological strains and medicines.
South Africa Today
Read more at VolaNews
